2022 SHORTLIST
Best ADC Platform Technology
IntoCell
Catalent's SMARTag Technology
Tubulis GmbH
Ajinomoto Bio-Pharma Services
Synaffix
Most Promising Clinical Candidate
DS-1062a (Daiichi Sankyo / AstraZeneca)
Patritumab deruxtecan (Daiichi Sankyo)
Mirvetuximab soravtansine (ImmunoGen)
Trastuzumab duocarmazine (Byondis)
Camidanlumab tesirine
(ADC Therapeutics)
Best New Drug Developer
Exelixis
Tubulis GmbH
Adcendo
Iksuda Therapeutics
Adcentrx
Best CMO
WuXi Biologics
MilliporeSigma
Catalent Pharma Solutions
Ajinomoto Bio-Pharma Servies
BSP Pharmaceuticals
Best CRO
Charles River Laboratories
NJ Biopharmaceuticals
Covance
Abzena
Eurofins